Streetbeat News

Revenues

GILD

In the last three months, 12 analysts have provided diverse ratings on Gilead Sciences (NASDAQ:GILD), with a recent average price target of $84.42, marking a 5.15% decrease from the previous $89.00. The ratings range from bullish to bearish, reflecting varied perspectives on the company's performance. Gilead Sciences, known for its life-threatening infectious disease therapies, faces financial challenges with a -3.72% revenue decline and below-average profitability metrics. Analysts' adjustments in ratings and price targets highlight the evolving market sentiment towards Gilead's stock.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 7:00 pm

NKE

Nike announced it will lay off 740 workers at its Oregon headquarters as part of a second wave of mass layoffs, following a previous announcement by CEO John Donahoe of a 2% workforce reduction. The layoffs, which are part of a broader restructuring effort aimed at cutting $2 billion in costs over three years, do not affect Nike's store, distribution center, or U.S. manufacturing facility employees. This move comes amid a sales slump and market share loss to competitors, with Nike projecting only a 1% sales increase for the fiscal year ending May 31 and expecting sales to decline in the following six months before a projected acceleration due to new product launches.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 6:47 pm

BANR

Banner Corp (NASDAQ:BANR) received mixed analyst ratings with a recent average price target of $51.2, down from $52.60. Analysts from firms like Piper Sandler and DA Davidson adjusted their ratings and price targets, reflecting a nuanced view on Banner's financial health, which shows strong profitability but challenges in revenue growth.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 6:01 pm

MGNI

Magnite (NASDAQ:MGNI) was analyzed by 11 financial analysts, showing a range of opinions from bullish to bearish. Recent ratings indicate a shift towards a more positive outlook, with an average 12-month price target of $15.5, up 16.28% from the previous $13.33. Analyst actions include maintaining and raising ratings and price targets, reflecting optimism about Magnite's market performance and financial health. The company, a leading SSP in online advertising, has shown solid revenue growth and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 6:01 pm

SWN

Six analysts have maintained a neutral stance on Southwestern Energy (NYSE:SWN) over the last three months, with no change in the average 12-month price target of $7.6. Analyst actions include both raises and lowers in price targets, reflecting a nuanced view of the company's prospects. Southwestern Energy faces significant financial challenges, including a -49.94% revenue decline, a net margin of -38.89%, and a debt-to-equity ratio of 0.7, indicating potential difficulties in profitability and debt management.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 6:01 pm

OLN

Analysts have mixed views on Olin (NYSE:OLN), with recent ratings ranging from bullish to indifferent. Over the past three months, 11 analysts have provided evaluations, with a notable shift in sentiment in the last 30 days. The average 12-month price target for OLN has increased to $63.64, up 8.69% from the previous $58.55. Analysts from firms like RBC Capital, Citigroup, and Keybanc have raised their price targets, reflecting a positive outlook on the stock. Olin Corp, a chemical manufacturer, faces challenges with a -18.33% revenue decline over 3 months but maintains strong profitability metrics.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 6:01 pm

EVER

Analyst ratings for EverQuote (NASDAQ:EVER) show a mix of bullish and bearish perspectives with a recent shift towards more positive evaluations. The average 12-month price target for EVER has increased significantly to $22.00, up 57.14% from the previous $14.00, indicating a positive outlook from analysts. EverQuote's financial performance shows challenges in revenue growth and efficiency in utilizing assets and equity, but it maintains a strong net margin and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 6:00 pm

DMTK

DermTech (NASDAQ:DMTK) received mixed analyst ratings with a shift towards a more cautious stance in the last quarter. The average 12-month price target was adjusted to $1.41 from a previous $3.25, indicating a significant downward revision. Analysts from Lake Street, Stephens & Co., and BTIG provided updates, with actions ranging from maintaining to lowering ratings and price targets. DermTech's financial overview shows a positive revenue growth rate of 31.06% but challenges in debt management and net margin.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 5:01 pm

HTHT

In the last three months, 5 analysts have updated their ratings on H World Group (NASDAQ:HTHT), showing a shift towards a more bullish outlook. The average 12-month price target has been raised to $48.00, up from $45.50, with a range between $40.00 and $64.00. Analyst actions include maintaining, raising, and lowering ratings, reflecting their adaptation to market conditions and H World Group's performance. The company has shown significant revenue growth and profitability, with a revenue increase of 53.63% and a net margin of 21.26%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 5:00 pm

FBIN

Fortune Brands (NYSE:FBIN) has been analyzed by 4 analysts, showing a shift towards a more neutral stance in the last three months with an average 12-month price target of $86.75, up from $83.75. The company, a leader in home and security products, has seen positive revenue growth but faces challenges in profitability, ROE, ROA, and a high debt-to-equity ratio. Analysts' ratings and price targets reflect their views on the company's market conditions and performance.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 5:00 pm